HFRG
CTSO icon

Houlihan Financial Resource Group’s Cytosorbents Corp CTSO Stock Holding History

Houlihan Financial Resource Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,600
Closed -$59K – 110
2023
Q2 		$59K Buy
+18,600
New +$58.8K ﹤0.01% 134
2020
Q3 		$2K Buy
+300
New +$2.71K ﹤0.01% 309

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Houlihan Financial Resource Group's CTSO Position: Q3 2023 in Review

Houlihan Financial Resource Group sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 18,600 shares — an estimated $59K sold.

Houlihan Financial Resource Group first reported a position in CTSO in Q3 2020 and held it in 2 quarters. The position peaked at $59K in Q2 2023. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • Houlihan Financial Resource Group reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • Houlihan Financial Resource Group sold 18,600 Cytosorbents Corp shares in Q3 2023, an estimated $59K.
  • Houlihan Financial Resource Group first reported a position in Cytosorbents Corp in Q3 2020 and held it in 2 quarters.
  • Houlihan Financial Resource Group's Cytosorbents Corp position peaked at $59K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2023, filed 9 Nov 2023.